Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
Infection and Immunity|June 16, 2010
Genome organization and pathogenicity of Corynebacterium diphtheriae C7(-) and PW8 strainsMasaaki Iwaki, Takako Komiya, Akihiko Yamamoto, et al.Microbiology and Immunology|March 18, 2009
Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS modelKoji Ishii, Hideki Hasegawa, Noriyo Nagata, et al.Immunohorizons|April 28, 2022
Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection ModelNaoko Iwata-Yoshikawa, Noriyo Nagata, Hiromi Takaki, et al.Journal of Virology|May 18, 2007
Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptorSeii Ohka, Hiroko Igarashi, Noriyo Nagata, et al.Vaccine|April 17, 2009
Comparison of acellular pertussis-based combination vaccines by Japanese control tests for toxicities and laboratory models for local reactionMichiyo Kataoka, Akihiko Yamamoto, Masaki Ochiai, et al.Comparative Immunology, Microbiology and Infectious Diseases|May 2, 2006
Development and biological properties of a new live attenuated mumps vaccineShizuko Saika, Minoru Kidokoro, Hiroko Kubonoya, et al.Journal of Virology|April 21, 2026
Modeling human enterovirus A71 infection using an intestinal microphysiological systemHiroki Futatsusako, Sayaka Deguchi, Kaori Kosugi, et al.Antiviral Research|May 25, 2005
Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirusMasayuki Saijo, Shigeru Morikawa, Shuetsu Fukushi, et al.The Journal of General Virology|April 16, 2005
Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeysMinetaro Arita, Hiroyuki Shimizu, Noriyo Nagata, et al.Antiviral Research|December 10, 2009
TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compoundsShiori Haga, Noriyo Nagata, Tadashi Okamura, et al.Pageof 13